<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The categorisation of <z:e sem="disease" ids="C0079734" disease_type="Neoplastic Process" abbrv="">lymphosarcomas</z:e> with immune markers has enriched the prognostic value of W.H.O. classification </plain></SENT>
<SENT sid="1" pm="."><plain>The prolymphocytic (centrofollicular B type and the null lymphoblastic subtype have a good prognosis while the (T or B) <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> type and the T-lymphoblastic subtype have a poor prognosis </plain></SENT>
</text></document>